Development and validation of a HPLC method for the determination of montelukast and its degradation products in pharmaceutical formulation using an experimental design

Acta Pharmaceutica Sciencia

Volumn 53, Issue 1, 2011, Pages 45-56

  Eldin, Ahmed B ^a   Shalaby, Abdalla A ^b   El Tohamy, Maha ^c  

^a Methodology Manager   (Egypt)

^b Zagazig University   (Egypt)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Experimental design; HPLC; Montelukast; Stability indicating method

Indexed keywords

ACETONITRILE; BUFFER; MONTELUKAST; POTASSIUM DIHYDROGEN PHOSPHATE;

ACCURACY; ACIDITY; ALKALINITY; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG DEGRADATION; DRUG DETERMINATION; DRUG STRUCTURE; EXPERIMENTAL DESIGN; FLOW RATE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; OXIDATION; PHOTODEGRADATION; RESPONSE SURFACE METHOD; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; TABLET; VALIDATION STUDY;

EID: 79958152708     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Amin, R.D., Cheng, H. and Rogers, J.D. (1995). Determination of MK- 0476 in human plasma by liquid chromatography. J. Pharm. Biomed. Anal. 13: 155-163.
2. Currie, G.P. and McLaughlin, K. (2006). The expanding role of leukotriene receptor antagonists in chronic asthma. Ann Allergy Asthma Immunol 97: 731-741.
3. Dockhorn, R. J., Baumgartner, R. A., Leff, J. A., Noonan, M., Vandormael, K., Stricker, W., Weinland, D. E. and Reiss, T. F. (2000). Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 55: 260-265.
4. FDA Guidance for Industry (2007). Center for Drug Evaluation and Research (CDER). 2-20
5. Lewis, G.A., Mathieu, D. and Phan-Tan-Luu, R. (1999). Pharmaceutical Experimental Design. Marcel Dekker, New York
6. García-Marcos, L., Schuster, A. and Pérez-Yarza, E.G. (2003). Benefit-risk assessment of antileukotrienes in the management of asthma. Drug Saf. 26: 483-518.
7. Hoang, T.H., Farkas, R., Wells, C., McCliutock, S. and Maso, M.D. (2002). Application of pressurized liquid extraction technology to pharmaceutical solid dosage forms. J. Chromatogr. A 968: 257-261.
8. ICH - Q2R1(2005). Validation of analytical procedures, text and methodology. 1: 13
9. Kitchen, C.J., Wang, A.Q., Musson, D.G., Yang, A.Y. and Fisher, A.L. (2003). A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection. J. Pharm. Biomed. Anal. 31: 647-654.
10. Hockman, K.K. and Berengut, D. (2002). Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design. J. Pharm. Biomed. Anal. 6: 1097-1103.
11. Liu, L., Cheng, H., Zhao, J.J. and Rogers, J.D. (1997). Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching. J Pharm Biomed Anal. 15: 631-638.
12. Miller, J.C. and Miller, J.N. (1993). Statistic of analytical chemistry. Ellis Horwood PTR Prentice Hall, New York, pp125-135.
13. Ochiai, H., Uchiyama, N., Takano, T., Hara, K. and Kamei, T. (1998). Determination of montelukast sodium in human plasma by column-switching high performance liquid chromatography with fluorescence detection. J. Chromatogr. B. Biomed. Appl. 713: 409-414.
14. Radhakrishna, T., Narasaraju, A., Ramakrishna, M. and Satyanarayana, A. (2003). Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods. J. Pharm. Biomed. Anal. 31: 359-68.
15. Ragonese, R., Mulholland, M. and Kalman, J. (2000). Full and fractionated experimental designs for robustness testing in the high-performance liquid chromatographic analysis of codeine phosphate, pseudoephedrine hydrochloride and chlorpheniramine maleate in a pharmaceutical preparation. J. Chromatogr. A 870: 45-51.
16. United States Pharmacopoeia 34 - NF 29 (2011). Validation of compendial procedures. Monograph 1225: 549-554.
17. Vander Heyden, Y., Nijhuis, A.J. and Smeyers-Verbeke, B.G.M. (2001). Guidance for robustness/ruggedness tests in method validation. J. Pharm. Biom. Anal. 24: 723-753.